Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a culturally tailored app help native communities kick the habit?

NCT ID NCT06145763

First seen Feb 24, 2026 · Last updated Jun 20, 2026 · Updated 23 times

Summary

This study compares a new smartphone app called IndigeQuit to an existing app (NCI QuitGuide) to help American Indian and Alaska Native adults quit smoking. About 776 participants who smoke daily and want to quit within 30 days will be randomly assigned to use one of the apps. The goal is to see if IndigeQuit, designed with cultural relevance, leads to more people quitting smoking for at least 30 days.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CIGARETTE SMOKING-RELATED CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

IndigeQuit smartphone app (behavioral intervention)

What this could lead to

If successful, this could provide an effective, culturally tailored smoking cessation tool for American Indian and Alaska Native communities, reducing smoking-related cancers.

What could go wrong

This is a behavioral intervention trial, not a drug or cure. Success depends on user engagement and self-reporting, and results may not generalize to all AI/AN populations.

Conditions

The condition(s) this trial relates to.

squamous cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.